The global rheumatoid arthritis drugs market was valued at US$31.27 billion in 2024 and is projected to reach US$56.62 ...

Australian researchers have discovered that an anti-inflammatory drug already being used to treat rheumatoid arthritis could ...

Unlike typical osteoarthritis, where cartilage in joints breaks down, rheumatoid arthritis results from the immune system ...

The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

Osteoarthritis and Rheumatoid Arthritis sound similar but affect joints differently. Learn their early symptoms and treatment ...

Complementary therapies don't change the course of RA, but they may provide pain relief. Here are some add-on therapies to ...

Mar. 24 -- THURSDAY, March 6 (HealthDay News) -- People taking medications for rheumatoid arthritis may also be reducing their risk of heart attack and stroke, a new study suggests. People with ...

They’ve been approved for the US market since 2012, but Janus kinase (JAK) inhibitors are still the new kid on the block in terms of rheumatoid arthritis treatment. As such, the real-world evidence on ...

When you’re young, working long hours, commuting, sitting at a desk, it’s easy to blame joint aches on poor posture or ...

Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...

Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...